The Pentamaks study: Comparison of the first synthetic factor Xa inhibitor with low molecular weight heparin the prevention of venous thrombo embolism (VTE) after elective major knee surgery.

被引：0
|
作者：
Bauer, K [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2111
引用
收藏
页码：490A / 491A
页数：2
相关论文
共 35 条
  • [21] Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery (vol 9, pg 499, 1998)
    Planès, A
    Vochelle, N
    Foagola, M
    Bellaud, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (03) : 156 - 156
  • [22] AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery - TREK: a dose-ranging study
    Lassen, M. R.
    Dahl, O. E.
    Mismetti, P.
    Destree, D.
    Turpie, A. G. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) : 566 - 572
  • [23] Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: A double-blind dose-ranging study
    Heit, JA
    Berkowitz, SD
    Bona, R
    Cabanas, V
    Corson, JD
    Elliott, CG
    Lyons, R
    Ballard, WP
    Henderson, C
    Colwell, CW
    Comp, PC
    Eklof, B
    Friedman, R
    Goble, M
    Green, D
    Haire, W
    Hyers, T
    Ohar, J
    Incavo, S
    Kessler, C
    Lotke, P
    Moore, DE
    Pinzur, MS
    Godwin, J
    Sack, M
    Scott, WN
    Sterling, R
    Gouaux, J
    Stewart, J
    Suchyta, M
    Trowbridge, A
    Wengler, MK
    Winters, T
    Zaoutis, LB
    Holloway, DS
    DiLiberto, JM
    Rossi, MJ
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (01) : 32 - 38
  • [24] Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study
    Alzghari, Saeed K.
    Seago, Susan E.
    Garza, Jessica E.
    Hashimie, Yasmeen F.
    Baty, Kimberly A.
    Evans, Martha F.
    Shaver, Courtney
    Herrington, Jon D.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 494 - 500
  • [25] PREVENTION OF DEEP-VEIN THROMBOSIS AFTER MAJOR KNEE SURGERY - A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT (ENOXAPARIN) TO PLACEBO
    LECLERC, JR
    GEERTS, WH
    DESJARDINS, L
    JOBIN, F
    LAROCHE, F
    DELORME, F
    HAVIERNICK, S
    ATKINSON, S
    BOURGOUIN, J
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (04) : 417 - 423
  • [26] Subgroup analysis of the FONDACAST study comparing fondaparinux to low-molecular-weight heparin for the prevention of venous thromboembolism after an isolated, non-surgical below-knee injury
    Samama, C. M.
    Riou, B.
    Roy, P-M
    Sautet, A.
    Mismetti, P.
    Van der Veen, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 88 - 89
  • [27] Prevention of venous thromboembolism after an isolated, non-surgical below-knee injury. Benefit/risk of fondaparinux vs. low molecular weight heparin: the fondacast study
    Samama, C. M.
    Riou, B.
    Roy, P-M
    Sautet, A.
    Mismetti, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 5 - 5
  • [28] Achieving higher efficacy without compromising safety with Factor XI inhibitors versus low-molecular-weight heparin for the prevention of venous thromboembolism in major orthopedic surgery - Systematic Review and Meta-Analysis
    Presume, Joao
    Ferreira, Jorge
    Ribeiras, Regina
    Mendes, Miguel
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPP 2)
  • [29] Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis
    Presume, Joao
    Ferreira, Jorge
    Ribeiras, Regina
    Mendes, Miguel
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (12) : 2930 - 2938
  • [30] Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis
    Xin Lu
    Jin Lin
    BMC Musculoskeletal Disorders, 19
1234